Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive Therapy
暂无分享,去创建一个
L. Galli | A. Castagna | H. Hasson | G. Morsica | C. Uberti Foppa | E. Messina | Costanza Bertoni | Riccardo Lolatto | Alessia Siribelli | R. Lolatto
[1] Xin Li,et al. Peripheral immune factors aiding clinical parameter for better early recurrence prediction of hepatocellular carcinoma after thermal ablation. , 2023, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[2] Jiayin Yang,et al. A simple CD4+ T cells to FIB-4 ratio for evaluating prognosis of BCLC-B hepatocellular carcinoma: a retrospective cohort study , 2022, BMC cancer.
[3] L. Galli,et al. Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients , 2022, Journal of oncology.
[4] J. Bruix,et al. BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update. , 2021, Journal of hepatology.
[5] G. Esposito,et al. Liver Transplantation for HCC in HIV-Infected Patients: Long-Term Single-Center Experience , 2021, Cancers.
[6] Y. Mao,et al. The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real‐world data , 2021, Journal of clinical laboratory analysis.
[7] M. Spitzer,et al. Systemic immunity in cancer , 2021, Nature Reviews Cancer.
[8] H. Masur,et al. Retrospective‐prospective study of safety and efficacy of sofosbuvir‐based direct‐acting antivirals in HIV/HCV‐coinfected participants with decompensated liver disease pre– or post–liver transplant , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] Jiao Li,et al. Comparative analysis of presentation and outcome after liver resection of patients with hepatocellular carcinoma with and without HIV. , 2020, Journal of acquired immune deficiency syndromes.
[10] D. Serraino,et al. Excess liver‐related mortality among people with AIDS compared to the general population: an Italian nationwide cohort study using multiple causes of death , 2020, HIV medicine.
[11] B. Figueruela,et al. Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients. , 2020, AIDS.
[12] J. Fung,et al. Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong. , 2019, Translational gastroenterology and hepatology.
[13] A. Grigorian,et al. Long term outcomes of patients transplanted for hepatocellular carcinoma with human immunodeficiency virus infection. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[14] M. Zoli,et al. Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] M. Abecassis,et al. AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.
[16] D. Pinato,et al. The albumin‐bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV‐associated hepatocellular carcinoma , 2018, Alimentary pharmacology & therapeutics.
[17] Ping Chen,et al. The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma , 2017, Scientific Reports.
[18] Hong-Yang Wang,et al. Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms , 2017, Science China Life Sciences.
[19] O. Yokosuka,et al. Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma , 2017, Cancers.
[20] Sung‐Gyu Lee,et al. Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation. , 2016, Hepatobiliary surgery and nutrition.
[21] E. Montalvá,et al. Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence. , 2016, Transplantation proceedings.
[22] J. Bruix,et al. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.
[23] J. Miro,et al. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma , 2016, Hepatology.
[24] U. Tirelli,et al. Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity. , 2015, European review for medical and pharmacological sciences.
[25] O. Yokosuka,et al. The androgen receptor as an emerging target in hepatocellular carcinoma , 2015, Journal of hepatocellular carcinoma.
[26] G. Tan,et al. Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives. , 2015, Oncology letters.
[27] P. Morlat,et al. Liver‐related deaths in HIV‐infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey , 2015, HIV medicine.
[28] W. Fan,et al. Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Survival and Metastasis for Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization , 2015, PloS one.
[29] K. Koike,et al. The C-Reactive Protein/Albumin Ratio, a Novel Inflammation-Based Prognostic Score, Predicts Outcomes in Patients with Hepatocellular Carcinoma , 2015, Annals of Surgical Oncology.
[30] Jiyuan Zhang,et al. Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma , 2013, Hepatology.
[31] O. Farges,et al. Standardized Care Management Ensures Similar Survival Rates in HIV-Positive and HIV-Negative Patients With Hepatocellular Carcinoma , 2012, Journal of acquired immune deficiency syndromes.
[32] A. Singal,et al. Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[33] R. Lamerz,et al. Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort. , 2012, PloS one.
[34] Guoping Wang,et al. Long-Term Outcomes of Repeat Hepatic Resection in Patients with Recurrent Hepatocellular Carcinoma and Analysis of Recurrent Types and Their Prognosis: A Single-Center Experience in China , 2012, Annals of Surgical Oncology.
[35] H. El‐Serag,et al. Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[36] B. Gazzard,et al. Increasing burden of liver disease in patients with HIV infection , 2011, The Lancet.
[37] A. Ruggieri,et al. Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity , 2010, International journal of cancer.
[38] Jiamei Yang,et al. Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review , 2010, World journal of surgical oncology.
[39] G. Guaraldi,et al. Hepatocellular carcinoma in HIV-infected patients: check early, treat hard. , 2011, The oncologist.
[40] M. Zoli,et al. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? , 2009, European journal of gastroenterology & hepatology.
[41] N. Probst-Hensch,et al. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma , 2008, Infectious Agents and Cancer.
[42] Joris R Delanghe,et al. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[43] Anne M Johnson,et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. , 2008, JAMA.
[44] P. Sullivan,et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. , 2008, Annals of internal medicine.
[45] E. Bini,et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. , 2007, Journal of hepatology.
[46] JD Lundgren,et al. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study , 2007, The Lancet.
[47] Charles E McCulloch,et al. Relaxing the rule of ten events per variable in logistic and Cox regression. , 2007, American journal of epidemiology.
[48] Peter J. Richardson,et al. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. , 2004, Archives of internal medicine.
[49] R. Bruno,et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome , 2004, AIDS.
[50] S. Kawasaki,et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. , 2003, Journal of hepatology.
[51] S. Fan,et al. Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function: Implications for a Strategy of Salvage Transplantation , 2002, Annals of surgery.
[52] M. Dumont,et al. European Association for the Study of the Liver , 1971 .
[53] Y. Maehara,et al. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. , 2013, Journal of hepatology.
[54] J. Bruix,et al. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.
[55] C. G. Child,et al. Surgery and portal hypertension. , 1964, Major problems in clinical surgery.